Cyclo Therapeutics soars 10% on launch of Phase 3 Trappsol Cyclo study in rare genetic disorder
June 17 2021 - 8:28AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cyclo Therapeutics (NASDAQ:CYTH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cyclo Therapeutics (NASDAQ:CYTH)
Historical Stock Chart
From Sep 2023 to Sep 2024